Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

α-cell electrophysiology and the regulation of glucagon secretion

Gao, Rui ; Acreman, Samuel ; Ma, Jinfang ; Abdulkader, Fernando ; Wendt, Anna LU and Zhang, Quan (2023) In The Journal of endocrinology 258(2).
Abstract

Glucagon is the principal glucose-elevating hormone that forms the first-line defence against hypoglycaemia. Along with insulin, glucagon also plays a key role in maintaining systemic glucose homeostasis. The cells that secrete glucagon, pancreatic α-cells, are electrically excitable cells and use electrical activity to couple its hormone secretion to changes in ambient glucose levels. Exactly how glucose regulates α-cells has been a topic of debate for decades but it is clear that electrical signals generated by the cells play an important role in glucagon secretory response. Decades of studies have already revealed the key players involved in the generation of these electrical signals and possible mechanisms controlling them to tune... (More)

Glucagon is the principal glucose-elevating hormone that forms the first-line defence against hypoglycaemia. Along with insulin, glucagon also plays a key role in maintaining systemic glucose homeostasis. The cells that secrete glucagon, pancreatic α-cells, are electrically excitable cells and use electrical activity to couple its hormone secretion to changes in ambient glucose levels. Exactly how glucose regulates α-cells has been a topic of debate for decades but it is clear that electrical signals generated by the cells play an important role in glucagon secretory response. Decades of studies have already revealed the key players involved in the generation of these electrical signals and possible mechanisms controlling them to tune glucagon release. This has offered the opportunity to fully understand the enigmatic α-cell physiology. In this review, we describe the current knowledge on cellular electrophysiology and factors regulating excitability, glucose sensing, and glucagon secretion. We also discuss α-cell pathophysiology and the perspective of addressing glucagon secretory defects in diabetes for developing better diabetes treatment, which bears the hope of eliminating hypoglycaemia as a clinical problem in diabetes care.

(Less)
Please use this url to cite or link to this publication:
author
; ; ; ; and
organization
publishing date
type
Contribution to journal
publication status
published
subject
keywords
diabetes, electrophysiology, glucagon, α-cell
in
The Journal of endocrinology
volume
258
issue
2
publisher
Society for Endocrinology
external identifiers
  • pmid:37159865
  • scopus:85164051057
ISSN
1479-6805
DOI
10.1530/JOE-22-0295
language
English
LU publication?
yes
id
4613800d-d597-4c42-92c4-8c661e8973f6
date added to LUP
2023-09-05 10:22:17
date last changed
2024-04-20 03:37:01
@article{4613800d-d597-4c42-92c4-8c661e8973f6,
  abstract     = {{<p>Glucagon is the principal glucose-elevating hormone that forms the first-line defence against hypoglycaemia. Along with insulin, glucagon also plays a key role in maintaining systemic glucose homeostasis. The cells that secrete glucagon, pancreatic α-cells, are electrically excitable cells and use electrical activity to couple its hormone secretion to changes in ambient glucose levels. Exactly how glucose regulates α-cells has been a topic of debate for decades but it is clear that electrical signals generated by the cells play an important role in glucagon secretory response. Decades of studies have already revealed the key players involved in the generation of these electrical signals and possible mechanisms controlling them to tune glucagon release. This has offered the opportunity to fully understand the enigmatic α-cell physiology. In this review, we describe the current knowledge on cellular electrophysiology and factors regulating excitability, glucose sensing, and glucagon secretion. We also discuss α-cell pathophysiology and the perspective of addressing glucagon secretory defects in diabetes for developing better diabetes treatment, which bears the hope of eliminating hypoglycaemia as a clinical problem in diabetes care.</p>}},
  author       = {{Gao, Rui and Acreman, Samuel and Ma, Jinfang and Abdulkader, Fernando and Wendt, Anna and Zhang, Quan}},
  issn         = {{1479-6805}},
  keywords     = {{diabetes; electrophysiology; glucagon; α-cell}},
  language     = {{eng}},
  number       = {{2}},
  publisher    = {{Society for Endocrinology}},
  series       = {{The Journal of endocrinology}},
  title        = {{α-cell electrophysiology and the regulation of glucagon secretion}},
  url          = {{http://dx.doi.org/10.1530/JOE-22-0295}},
  doi          = {{10.1530/JOE-22-0295}},
  volume       = {{258}},
  year         = {{2023}},
}